A core part of our work is to lead and contribute to the latest research into psychedelic programs that could lead to improved availability of psychedelic programs in the U.S. and improved quality of care for veterans suffering from PTSD, Traumatic Brain Injury, and more. As evidence for the benefits of psychedelics continues to grow, it becomes easier to increase access to psychedelic programs for those in need.
We have collaborated over the years with researchers at some of the world’s leading scientific institutions to study the impacts of psychedelics on the psychology and physiology of veterans with PTSD, Traumatic Brain Injury, and other military and combat related trauma. Organizations we’ve worked in partnership with include but are not limited to:
Under the direction of Dr. Grace Blest-Hopley in the United Kingdom, we are currently conducting a large observational study of over 400 veterans in real-world, HHP-program settings.
In the 60’s and 70’s, psychedelic research in the U.S. was completely shut down for an entire generation due to the optics of the War on Drugs. Today, the scientific study of psychedelics and PTSD are advancing at an unprecedented clip. Worldwide, there are hundreds of ongoing research projects into the medical applications of psychedelics…this number grows every year.
There is already substantial evidence that psychedelics such as MDMA, psilocybin, and LSD can alleviate or reduce anxiety, depression, addiction, PTSD and fear approaching end of life. Psychedelics are also shown to have lasting improvements on creativity, the ability to connect to others and overall life satisfaction.
New brain imaging technologies (such as magnetoencephalography, magnetic resonance imaging, functional magnetic resonance imaging, diffusion tensor imaging, positron emission tomography, magnetoencephalography, and macromolecular proton fraction mapping), new methods of data collection and analysis (such as computer modeling), and new scientific areas of study (such as epigenetics and pharmacogenomics) have the potential to revolutionize our understanding of the brain and how to heal PTSD as effectively as possible.
“…It becomes increasingly important to monitor (psychedelic) use and utility outside of clinical and laboratory settings—which would not be possible without the efforts of the brilliant team at Heroic Hearts, UK.”
Dr. Robin Carhart-Harris,
The Centre for Psychedelic Research,
Imperial College, United Kingdom.
Psychedelic retreat participants volunteer to wear EEG caps and monitors that measure other physical functions during a retreat, resulting in a rich multi-dimensional set of real-time data that has never before been collected. The data will measure effectiveness of HHP psychedelic retreats in the real world and help improve healing processes.
September 11, 2025
A major new study published in Brain and Behavior provides evidence on something Heroic Hearts has long believed: therapeutic, well-supported psychedelic retreats can catalyze deep…
A new peer-reviewed study, published this week in Frontiers in Psychiatry, is shining a spotlight on what many of our veterans already know firsthand: psilocybin…
Heroic Hearts Project is proud to partner with Vivian Rosenthal of Frequency Breathwork and Dr. Adam Hanley of Florida State University on a new research study exploring…
April 1, 2025
Written by: David Connell The mental health crisis among U.S. military veterans is an ongoing and urgent issue, with post-traumatic stress disorder (PTSD) and suicide…
